Register Login

ADMA BIOLOGICS, INC. (ADMA)

Guiheen Lawrence P. 🟡 adjusted position in 0 shares (1 derivative) of ADMA BIOLOGICS, INC. (ADMA) at $3.66 Transaction Date: Mar 13, 2026 | Filing ID: 009900

Full text
Register to leave comments
  • News bot March 18, 2026, 1:01 a.m.

    🔍 Guiheen Lawrence P. (Executive)

    Company: ADMA BIOLOGICS, INC. (ADMA)

    Report Date: 2026-03-13

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 1
    • Holdings reported: 1
    • Total shares acquired: 60,000
    • Total shares sold: 60,000
    • Total shares held: 50,990

    Detailed Transactions and Holdings:

    • Acquired 30,000 shares of Common Stock at $3.66 per share (Direct)
      Date: 2026-03-13 | Code: M | equity_swap_involved: 0 | shares_owned_after: 135,520.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 30,000 shares of Common Stock (Direct)
      Date: 2026-03-17 | Code: G | equity_swap_involved: 0 | shares_owned_after: 105,520.00 | transaction_form_type: 4 | Footnotes: F2, F1
    • Acquired 30,000 shares of Common Stock (Direct)
      Date: 2026-03-17 | Code: G | equity_swap_involved: 0 | shares_owned_after: 30,000.00 | transaction_form_type: 4 | Footnotes: F2, F3
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-03-13 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 50,990.00 | Footnotes: F4
    • Sold 30,000 shares of Stock Option (Right to Buy) at $3.66 per share (Derivative)
      Date: 2026-03-13 | Code: M | Expires: 2027-06-06 | equity_swap_involved: 0 | shares_owned_after: 23,837.00 | transaction_form_type: 4 | Footnotes: F5, F6

    Footnotes:

    • F1: Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; and (ii) 94,830 shares of common stock owned by the Reporting Person.
    • F2: This transaction involved the Reporting Person's gift of 30,000 shares of Issuer common stock to the Lawrence P Guiheen Irrevocable Trust DTD 9/20/19, Arlene Guiheen TTEE, Katherine M Guiheen TTEE (the "2019 Guiheen Irrevocable Trust"), over which Mr. Guiheen retains control. The Reporting Person disclaims beneficial ownership of the securities held by the 2019 Guiheen Irrevocable Trust, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
    • F3: Includes 30,000 shares of common stock held in the 2019 Guiheen Irrevocable Trust.
    • F4: Includes 50,990 shares of common stock held in the Lawrence P Guiheen Irrevocable Trust 1.
    • F5: The Reporting Person is exercising this option due, in part, to its near-term expiration date.
    • F6: These options vested in twenty-four equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Search

News categories